Department of Radiation Oncology

Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN (2018) Schlichtig K, Lechner P, Grafe C, Ferstl B, Fuchs F, Hein A, Meidenbauer N, et al. Conference contribution Radiation and checkpoint Blockade in the treatment of metastases (2018) Hirschmann E, Gaipl U, Fietkau R, Distel L, Hecht M Conference contribution Predictive character of peripheral blood immunophenotype before and during treatment with PD-1 immune checkpoint inhibitors (interim analysis of the prospective phase IV ST-ICI trial) (2018) Hecht M, Harrer A, Rutzner S, Lettmaier S, Wolf W, Fietkau R, Frey B, Gaipl U Conference contribution Correction to expert consensus on re-irradiation for recurrent glioma (2018) Krauze AV, Attia A, Braunstein S, Chan M, Combs SE, Fietkau R, Fiveash J, et al. Journal article Association of Plane of Total Mesorectal Excision With Prognosis of Rectal Cancer: Secondary Analysis of the CAO/ARO/AIO-04 Phase 3 Randomized Clinical Trial (2018) Kitz J, Fokas E, Beissbarth T, Stroebel P, Wittekind C, Hartmann A, Rueschoff J, et al. Journal article Clinical outcome of concomitant vs interrupted BRAF inhibitor therapy during radiotherapy in melanoma patients (2018) Hecht M, Meier F, Zimmer L, Polat B, Loquai C, Weishaupt C, Forschner A, et al. Journal article Radiochemotherapy of bladder cancer. An alternative to radical cystectomy (2018) Rodel C, Ott O, Weiss C Journal article Acquired temozolomide resistance in human glioblastoma cell line U251 is caused by mismatch repair deficiency and can be overcome by lomustine (2018) Stritzelberger J, Distel L, Buslei R, Fietkau R, Putz F Journal article Dose calculation and verification of the Vero gimbal tracking treatment delivery (2018) Prasetio H, Wölfelschneider J, Ziegler M, Serpa M, Witulla B, Bert C Journal article Neoadjuvant rectal score as individual-level surrogate for disease-free survival in rectal cancer in the CAO/ARO/AIO-04 randomized phase III trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Journal article